Propofol Pain Reduction by Pre-Administration with 6% Hes (Hydroxyethyl Starch): A Prospective Randomized Double-Blinded Study
Ananya Sukul, Anindita Saha, Saurendra Nath Mitra, Arnab Chakraborty, Ratul Kundu
Author(s)Abstract
Background: Propofol is one of the most common intravenous induction agents used in day-to- day anaesthesia practice. It is often used for maintenance of anaesthesia and sedation as well. The study aimed to compare pain reduction during propofol injection following pre-emptive administration of 50 ml of 6% HES or 0.9% NS in ASA I–II patients aged 18–60 years undergoing elective surgery under general anaesthesia. While assessing pain severity, changes in blood pressure, heart rate following induction and postoperative recall of injection pain were also assessed. Material and Methods: This was a prospective, randomized, double-blinded study conducted in the Operation Theatre of Ruby General Hospital, Kolkata, from August 2022 to August 2023.A total of 140 patients were included in the study. Results: A total of 140 patients (70 HES, 70 NS) were studied. Baseline age, sex, ASA grading, and propofol dose were comparable between groups. From this study it was found that pre administration of 50ml HES prior propofol induction reduced the pain during intravenous propofol injection significantly at 30th, 40th, 50th and 60th sec after propofol induction and also helped to maintain the hemodynamics significantly after 2nd and 3rd min of propofol injection. It was also observed that none of the patients taken for this study, remembered propofol injection pain in the postoperative period. Conclusion: The study showed that pre administration of 50ml bolus of 6% HES significantly decreased the pain on injection with propofol in comparison with NS. It was also observed that 50ml bolus of 6% HES provided better hemodynamic stability.
Keywords: Injection Pain, Hydroxyethyl Starch, HES, Normal Saline, Pain Reduction, Haemodynamic Stability.